CME & Abstract Book

• CME Information and Learning Objectives
• Faculty Disclosure Information
• Tromovitch Award Abstract Session
• Clinical Pearls Abstract Session
• Scientific Abstract Session
• Clinical Abstract Session
• Rapid Pearl Abstract Session
• Poster Presentation List

 

 

 

---

Scientific & Clinical Abstracts

The Scientific Program Committee will give special consideration to original research that addresses the most urgent needs of our patients and the ACMS, including the following:

• Outcome and quality metrics in the field of cutaneous oncology
• Cost-effectiveness research on Mohs and reconstructive surgery
• Patient-reported outcomes
• Novel reconstruction techniques, particularly involving case series (single case reports are discouraged)
• Outcome and quality measures for frozen section slide procedures and pathologic interpretation

Review Process for Scientific & Clinical Abstracts

1. Members of the Scientific Program Committee independently review each abstract.
2. To ensure fairness, reviewers are blinded to the author(s) and/or institution(s) who submit the abstract.
3. Each reviewer independently scores the abstracts according to the significance, innovation, approach, and impact on the ACMS mission, and the field of Mohs and reconstructive surgery.
4. Priority is given to work that has not been presented or submitted elsewhere.
5. Acceptance is at the sole discretion of Scientific Program Committee, whose decision for oral versus poster presentation is final.

General Submission Guidelines for Scientific & Clinical Abstracts

1. The submission deadline is 11:59 pm PST on Monday, January 11, 2021.
2. In order to encourage broad representation of our members, the Scientific Program Committee will limit each person to one Scientific abstract or Clinical abstract podium (oral) presentation and one Rapid Pearl presentation (oral). Each member may serve as a co-author on more than one oral presentation or more than one poster presentation of a scientific abstract. Members accepted to present oral abstracts will remain eligible to present in invited non-abstract sessions.
3. To preserve the integrity of the blinded review process, abstracts with identifying information will be disqualified. Eliminate all identifying words or phrases, including, but not limited to, author names, author institutions, industry affiliations, or geographic locations in the abstract body, image files, and file names.
4. In accordance with the Accreditation Council for Continuing Medical Education guidelines, “Educational materials that are part of a CME activity, such as abstracts, cannot contain any advertising, trade name or a product-group message” within the abstract.
5. General submissions must include preliminary or completed data to demonstrate that research is underway and will be completed prior to the date of the Annual Meeting. Tromovitch-eligible abstracts must include complete data analysis at the time of submission.
6. Scientific abstract submissions must include: Introduction & Objectives, Study Type, Study Setting, Methods, Results, and Conclusion.
7. Clinical abstract submissions must include: Purpose, Summary, Design, and Conclusion.
8. Literature reviews will not be considered for acceptance unless systematic review/meta-analysis methodology is used with results reported.
9. Abstracts that do not have an ACMS member or Fellow-in-Training as an author must include a curriculum vitae of the primary author at the time of submission. The Scientific Program Committee will remain blinded to authorship during the review process.
10. There is a strict 450-word limit.  Author information and uploaded images will not count toward the 450-word limit.
11. Abstracts may include up to 3 files or graphics uploaded in GIF, or JPEG format and no larger than a combined 10MB.
12. No changes or additions may be made to the abstract after the submission deadline.
13. All authors of accepted abstracts will be required to disclose any commercial conflicts of interest, which the Scientific Program Committee will review and consider for disqualification.

Abstract submission is closed.

 

---

Tromovitch Award Abstract Competition

Scientific abstracts with a primary author who is a Fellow-in-Training or who is in his or her first year of practice after completing a fellowship in Micrographic Surgery & Dermatologic Oncology will be eligible for the Tromovitch Award Abstract Competition.

1. The submission deadline is 11:59 pm PST on Monday, January 11, 2021.
2. Eligibility:  the primary author of the abstract must be a Fellow-in-Training or in the first year after completing a fellowship in Micrographic Surgery & Dermatologic Oncology.
3. The abstract must present original research done by the Fellow-in-Training during his or her year of training.
4. Tromovitch-eligible abstracts must include complete data analysis at the time of submission.
5. Authors must indicate on the submission website that he/she is applying for the Tromovitch Award Abstract Competition.
6. Tromovitch-eligible abstracts must follow the General Submission Guidelines outlined in the Call for Abstracts.
7. The Scientific Program Committee & Tromovitch Award Committee review all Tromovitch-eligible abstracts and decide which ones will be accepted for the Annual Meeting.
8. Authors of accepted abstracts must give an oral presentation at the Annual Meeting to be eligible for the Tromovitch Award.
9. After the oral presentations at the Annual Meeting, the judges of the Tromovitch Award will choose the winner based on the originality of the work, the quality of the science, the relevance to the field of Mohs and reconstructive surgery, and the quality of the oral presentation. In some years, there may be no award.
10. The recipient of the Tromovitch Award must submit an article suitable for publication in the Journal of Dermatologic Surgery by March of the following year. Upon receipt of the article by the Journal, the recipient of the award will receive complimentary membership dues for his or her first year of membership in the ACMS and free registration for the Annual Meeting of the following year.

---

Rapid Pearl Abstracts

This session gives the ACMS membership an opportunity to share a pearl with colleagues via an oral presentation during the plenary session.  Rapid Pearl presenters must submit their final slides in handout format, with the exception of video files, for availability in the Annual Meeting mobile app. The Scientific Program Committee will give special consideration to Rapid Pearls abstracts that address the following topics:

• Mohs surgery technique
• Frozen section pathology
• Reconstructive surgery
• Practice management

Review Process for Rapid Pearl Abstracts

1. Members of the Scientific Program Committee independently review each abstract.
2. To ensure fairness, reviewers are blinded to the author(s) and/or institution(s) who submit the abstract.
3. Each reviewer independently scores the abstracts based on the novelty of the pearl, its relevance to ACMS members, and the overall quality of the submission, including clarity of photographs or video.
4. Acceptance is at the sole discretion of Scientific Program Committee.

General Submission Guidelines for Rapid Pearl Abstracts

1. The submission deadline is 11:59 pm PST on Monday, January 11, 2021.
2. Submission is limited to ACMS members, and each member may submit only one pearl.
3. The Scientific Program Committee will limit each person to one Rapid Pearl presentation and one scientific abstract podium (oral) presentation.
4. Presenters must submit their final slides in handout format, with the exception of video files, to make available in the Annual Meeting mobile app.
5. The submission must be in the form of a PDF of a PowerPoint presentation designed for a 2-minute presentation (no more than 8 slides per presentation), and/or a video edited to a maximum length of 1 minute and no larger than 100 MB. Submissions exceeding these parameters will be disqualified.
6. To preserve the integrity of the blinded review process, submissions with identifying information will be disqualified. Eliminate all identifying words or phrases, including, but not limited to, author names, author institutions, industry affiliations, or geographic locations in the PDF/movie and in file names.
7. All submissions must be HIPAA-compliant. If any photos or videos allow patient identification, the applicant must indicate that the patient has provided consent. If the abstract is selected for presentation, the author must provide a copy of the consent form for final acceptance.
8. In accordance with the Accreditation Council for Continuing Medical Education guidelines, “Educational materials that are part of a CME activity, such as abstracts, cannot contain any advertising, trade name or a product-group message” within the abstract.
9. No changes or additions may be made to the abstract after the submission deadline. All authors of accepted abstracts will be required to disclose any commercial conflicts of interest, which the Scientific Program Committee will review and consider for disqualification.

---

Fellows-in-Training Clinicopathologic Case Competition

Fellows-in-Training are invited to submit clinicopathologic slides and photographs of Mohs cases that have uncommon or rare pathology or that illustrate prototypical diagnostic challenges and keys to diagnosis or tumor detection.  The winner will be invited to present the case during a plenary session at the Annual Meeting.

The ACMS will develop a library of interesting cases for an online teaching set, which all Fellows-in-Training and members of the ACMS may access.

Review Process for Fellows-in-Training Clinicopathologic Case Competition

1. Members of the Slide Quality Review Committee independently reviews each submission.
2. To ensure fairness, reviewers are blinded to the author(s) and/or institution(s) who submit the case.
3. Each reviewer independently scores the case based on:

• Rarity of the pathology
• Relevance to ACMS members
• Quality of the clinical photographs and frozen section histology
• Delivery of educational points
• Organization and coherence of the clinical question/interest

4. Acceptance is at the sole discretion of the Slide Quality Review Committee.

General Submission Guidelines for Fellows-in-Training Clinicopathologic Case Competition

1. Case submissions must be received by the ACMS office by Friday, February 12, 2021. No cases will be accepted after this deadline.
2. Fellows-in-Training will receive an email from Dustin Syrjanen containing submission guidelines and forms. Submissions must include clinical history, clinical question or interest (not to exceed 3 pages), and clinical references.
3. Slides are limited to 5 per submission and must be a standard size of 26x76 mm, with a thickness of 0.9 to 1.2 mm, including coverslip.
4. Return submission form along with labeled histology slides to the ACMS office. All histology slides will be digitally scanned and returned. If you are interested in sending slides digitally
5. Please submit clinical photographs associated with your interesting case. All photographs must be digitally submitted. All photographs should be original. They must be saved as TIF or JPG files. Please remember that the ACMS considers the manipulation of photographs used in the media, journals, scientific meetings, and in presentation to patients for the purpose of deceiving the audience to be against the ethical standards of the ACMS.
6. A consent form must accompany all recognizable photographs, including photos of any portion of the central face (eyes, nose, and/or mouth) and images that contain tattoos.